An immunology, nanomedicine, and cell banking expert. I started my academic career at the University of Arkansas where I majored in biomedical engineering. From there, I was involved in research and decided to pursue my PhD at Washington University in St. Louis. My thesis focused on using nanoparticles to improve the efficacy of cancer therapy. Projects included using liposomes to redirect T cells for the lysis of cancer, tumor microenvironment-targeting nanoparticles for the enhancement of multiple myeloma treatment, and a patient-derived biomaterial for the prediction of drug therapy efficacy.

During my time at WashU, I fell in love with immunology while I was working with T cells which led to me to continue my research endeavors in lung immunology at Brigham and Women’s Hospital. My postdoc lab focused on lung type 2 inflammation, and my project specifically focused on exploiting the role of mast cells in lung type 2 inflammation.

I went on to teach courses at Northeastern University related to understanding the key regulatory steps for transitioning medical innovations from the lab bench to the market which included current Good Manufacturing Practices, FDA applications, ICH guidance, etc. Then I shifted from teaching principles of cGMP to practicing them as a Cell Bank Engineer where I am manufacturing commercial products for Takeda. I’ve always loved mentoring which is why I’m back to teaching part-time. Please reach out for any questions or inquiries.